Get the Facts

Do you have trouble falling asleep?

According to the Centers for Disease Control (CDC), difficulty in falling asleep is one of the most under-reported medical problems in the United States, affecting more than 50 million of us. The affect of the lack of sleep on our lives is significant.

self reported sleep related sleep difficulties

How many people suffer with Insomnia?

Insomnia may be experienced for a few days, for two to three weeks, or it may be chronic, lasting for three weeks or more. Many people experience insomnia, particularly women before and at the onset of the menstrual cycle, during pregnancy and menopause. You may need to see a physician or sleep specialist.

  • Forty-eight percent of Americans report insomnia occasionally, while 22 percent experience insomnia every or almost every night.1
  • Women are 1.3 times more likely to report insomnia than men.1
  • People over age 65 are 1.5 times more likely to complain of insomnia than younger people.1
  • Divorced, widowed and separated people report more insomnia.1

Insomnia can have a very serious impact on quality of life, productivity and safety

  • People with insomnia are four times as likely to suffer from depression than people who sleep well.2
  • Lack of sleep due to insomnia may contribute to illness, including heart disease 3
  • Safety on the job, at home, and on the road may be affected by sleepiness.2
  • People with insomnia may miss more time from work or receive fewer promotions.2

1. Center for Disease Control, Behavioral Risk Factor Surveillance System (BRFSS), 2009

2. Strine TW, Chapman DP. Associations of frequent sleep insufficiency with health-related quality of life and health behaviors.  Sleep Med 2005;6:23–7.

3. Institute of Medicine.  Sleep disorders and  sleep  deprivation:  an unmet public  public health problem. Washington, DC. National Academies Press; 2006.

Feeling Frustrated? – Maybe Zolpimist Can Help

If you or someone you know are not satisfied with your current insomnia treatment, know that you are not alone. Consider having a discussion with a doctor to review your treatment options. Zolpimist may be the right solution. Find out how to start the conversation with your doctor HERE.

Know the signs

openArrow

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

Important Safety Information

READ MORE

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

Important Safety Information

download

Zolpimist (zolpidem tartrate) Oral Spray, a gamma-aminobutyic acid (GABA) A agonist, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate has been shown to decrease the time it takes to fall asleep for up to 35 days in controlled clinical studies.

.

Important Safety Information

.

Zolpimist is indicated for the short-term treatment of insomnia.

.

When you first start taking Zolpimist and until you know how you will react to this medication, use caution in the morning when you engage in activities requiring complete alertness. In most instances, memory problems can be avoided if you take Zolpimist only when you can sleep full night (e.g., 7 to 8 hours) before your planned awakening time. As with any sleep medication, do not use alcohol while you are taking Zolpimist. Tell your provider about all your health conditions and all the medicines you take, including prescriptions, nonprescriptions, and dietary supplements.

.

Sleepwalking, eating, or driving while not fully awake, without memory of the event, and rare incidents of allergic reactions, have been reported. If you have any of these experiences, contact your provider immediately.

.

Prescription sleep medicines are often taken for 7 to 10 days, perhaps longer if prescribed by your provider. Like many sleep aids, Zolpimist has some risk for dependency.

.

With short-term use, Zolpimist has a low incidence of side effects. In clinical trials, the most commonly reported side effects were drowsiness (2%), dizziness (1%), and diarrhea (1%).

.

The recommended initial Zolpimist dosage for women and elderly persons is 5 mg, for men 5 mg or 10 mg, immediately before bedtime, with at least 7 -8 hours remaining before the planned time of awakening.

.

To report suspected adverse events or product complaints, please email Aytu BioScience at zolpimist@aytubio.com; FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.